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Sumuunl The cytotoxic potency of 4-alkylamino-5-nitroquinoline drugs in AA8 cell cultures is enhanced up
to 60-fold under hypoxia, with wide variations in selectivity for hypoxic cells observed for different members
of this series. This study uses three representative 5-nitroquinolines to examine whether these differences in
hypoxia-selective cytotoxicity are cell line specific. and to explore quantitatively the oxygen dependence of the
cytotoxicity and metabolism of these compounds. The parent compound 5NQ, its 8-methyl analogue (8Me-
5NQ) and the 8-methylamino analogue (8NHMe-5NQ) each showed similar hypoxic selectivity (ratio of
concentration x time for 90% kill for zero versus 20% oxygen of 13-18-, 30-69- and 1.2-1.4-fold respectively
in the three cell lines tested (AA8 Chinese hamster ovary. EMT6/Ak mouse mammary tumour and FME
human melanoma). The cytotoxicity and metabolism (covalent binding) of radiolabelled 8Me-5NQ was
investigated in AA8 cultures over a range of oxygen tensions (0-95%). The oxygen tension in solution
required for 50% inhibition of log cell kill or adduct formation observed under anoxia (Cmo) was 0.01 and
0.02% oxygen respectively, suggesting that bioreductive alkylation is the mechanism of 8Me-5NQ toxicity. The
K-value (oxygen concentration for cytotoxic potency equal to the mean of the potencies at zero and infinite
oxygen) was similar (0.02% oxygen). Calculations based on measured rate constants for formation of the
nitroradical anion of 8Me-5NQ and rates of radical loss through disproportionation or reaction with oxygen.
predict a K-value for 8Me-5NQ of 0.025% oxygen. in good agreement with the experimentally determined
value. Modelling of cell killing expected by the combination of 8Me-5NQ plus radiation suggested that tumour
cells at intermediate oxygen tensions (0.01-1%) will be partially resistant to this treatment, and would limit
the use of these 5-nitroquinolines in combination with radiation, unless sufficient drug could be delivered to
cause extensive killing in the anoxic compartment.
It is widely recognised that there is a biologically significant
subpopulation of cells at low oxygen concentrations in many
human tumours (Thomlinson & Gray, 1955; Vaupel et al..
1989; Chapman, 1991; Mueller-Klieser et al.. 1991; Vaupel et
al.. 1991; H6ckel et al.. 1993). The resistance of these
predominantly non-cycling yet viable hypoxic cells to radia-
tion (and probably to many chemotherapeutic agents) has led
to the development of hypoxia-selective cytotoxins (HSCs),
which are designed to be activated selectively in the absence
of oxygen. Most HSCs are bioreductive drugs, their reductive
activation in aerobic cells being inhibited by reoxidation of
the initial one-electron reduction intermediate by oxygen
(Wilson, 1992). Since they eliminate radioresistant hypoxic
cells. HSCs have potential as tumour-selective radiation
enhancers; this strategy has recently been termed bioreduc-
tive radiotherapy' (Brown, 1991).
The 4-alkylamino-5-nitroquinoline derivative 8Me-5NQ
(Figure 1; R= Me) is a new and very selective HSC which
was designed as a DNA-targeted bioreductive agent (Denny
et al., 1991). It is 60 times more potent against anoxic than
aerobic cultures of Chinese hamster ovary AA8 cells (Denny
et al.. 1992), this differential being similar to that for two
HSCs currently under clinical investigation - RB 6145 and
tirapazamine (SR 4233) - which have anoxic aerobic differ-
entials of about 20-fold and 70-fold respectively in the AA8
line (this laboratory, unpublished data). Despite this very
high selectivity for anoxic cells in vitro, 8Me-5NQ has little
anti-tumour activity in combination with radiation in vivo
(Denny et al.. 1992), indicating that it is ineffective against
radiobiologically hypoxic cells in tumours.
Evaluation of structure-activity relationships within the
4-alkylamino-5-nitroquinoline series has revealed a wide
variation (1- to 60-fold) in hypoxia-selective cytotoxicity
towards AA8 cells (Denny et al., 1992). The basis of this
variation in selectivity is not currently understood. This series
therefore provides useful model compounds to investigate
determinants of hypoxia-selective cytotoxicity within a con-
generic series. As a first step in this process. three represen-
tative compounds with widely differing hypoxic selectivities
against the AA8 cell line have been chosen for more detailed
investigation. This study compares the highly selective 8Me-
5NQ (selectivity 60-fold) with the parent compound (5NQ.
Figure 1, R = H; selectivity 14-fold) and the 8-methylamino
derivative (8NHMe-5NQ, Figure 1, R = NHMe), which has
little selectivity for hypoxic AA8 cells (1.2-fold) (Denny et al..
1992). The cytotoxicities of these compounds are compared
in aerobic and anoxic cultures of three cell lines (AA8. the
human melanoma line FME and the murine mammary car-
cinoma line EMT6,Ak) to determine whether the pattern of
hypoxia-selective cytotoxicity observed in Chinese hamster
AA8 cells is observed in cell lines derived from other
species.
Most in vitro studies assess the hypoxia-selective cytotox-
icity of bioreductive agents by comparing cytotoxicity under
gas phases of 20% and 0% oxygen. While such comparisons
are useful in screening new bioreductive drugs, they are of
limited physiological significance since oxygen concentrations
as high as 20% are not encountered in either normal tissues
(typically I -5% oxygen; Vanderkooi et al., 1991) or tumours
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Figure 1 Structures of 4-alkvlamino-5-nitroquinoline drugs
investigated. 5NQ. R = H: 8Me-5NQ. R = Me; 8NHMe-5NQ.
R = NHMe.
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(Vaupel et al., 1991). Conversely, there are probably few, if
any, viable cells in tumours at 0% oxygen. Many tumour
cells are at oxygen tensions which might be termed 'inter-
mediate' (i.e. having a non-zero oxygen concentration, but
hypoxic in comparison with normal tissues) and which must
be taken into consideration in bioreductive radiotherapy.
Studies with misonidazole (MISO) (Taylor & Rauth, 1982;
Mulcahy, 1984), mitomycin C (Marshall & Rauth, 1986;
Rauth & Marshall, 1990), porfiromycin (Marshall & Rauth,
1988), diaziquone (Rauth & Marshall, 1990; O'Brien et al.,
1990), RSU 1069 (Koch, 1993) and the cobalt complex SN
24771 (Wilson et al., 1994) have indicated that for each of
these drugs the concentration of oxygen required for 50%
inhibition of the toxicity observed under anoxic conditions
(C,,) is very low (c. 0.01% oxygen). In contrast, cells are not
appreciably radiosensitised by oxygen until its concentration
exceeds about 0.1% (Chapman et al., 1974; Whillans &
Hunt, 1982). It has been pointed out that tumour cells at
intermediate oxygen tensions may therefore be too hypoxic
to be radiosensitive, but too well oxygenated to activate
bioreductive drugs efficiently, and may thus limit response to
combinations of HSCs with radiation (Marshall & Rauth,
1988; Rauth & Marshall, 1990).
Clearly, investigation of new bioreductive drugs should
consider the full range of physiological oxygen concentra-
tions to assess the maximum differential which could be
achieved in vivo, and to consider the contribution of cells at
'intermediate' oxygen to radioresistance in bioreductive was
radiotherapy. This study reports the cytotoxicity and meta-
bolic activation of 8Me-5NQ over a wide range of oxygen
concentrations, and compares this with the less selective
parent compound, 5NQ.
Materials and methods
Drugs
4-Alkylamino-5-nitroquinolines were prepared by published
methods (Stefanska et al., 1973; Denny et al., 1992). Fresh
drug solutions were prepared in culture medium [CM, alpha
minimal essential medium (a-MEM) containing 5% (v/v)
heat-inactivated foetal bovine serum (FBS) plus 100 IU ml-'
penicillin and 00 Lgml-' streptomycin] for each experiment
and were filter sterilised. Drug concentrations were checked
by spectrophotometry, after dilution in 0.01 M hydrochloric
acid, using extinction coefficients of 5,890 M-l cun' at
350nm for 5NQ; 7110M-'cmu1 at 352nm for 8Me-5NQ;
and 15,400 M- cm-' at 438 nm for 8NHMe-5NQ. 8Me-5NQ
was labelled by catalytic exchange against 3H20 (Amersham
International Ltd, Amersham, England) to prepare [quino-
linyl-G-3HJ-8Me-5NQ. After purification by flash chromato-
graphy on an alumina column this had a radiochemical
purity of 99.5% as determined by high-performance liquid
chromatography (HPLC) and a specific activity of
34 GBq mmol-'. A stock solution was prepared in 50% (v/v)
ethanol and stored at -80°C.
Cell culture
The AA8 cell line was obtained from L.H. Thompson
(Lawrence Livermore Laboratory, Berkeley, CA, USA), the
EMT6 line (designated EMT6/Ak in this laboratory) from I.
Tannock (Ontario Cancer Institute, Toronto, Canada) and
FME cells from K.M. Tveit (Norwegian Hydro Institute,
Oslo, Norway). Cultures were maintained in logarithmic-
phase growth in tissue culture flasks with weekly subculture
by trypsimsation using CM (without antibiotics) as growth
medium (the FBS concentration was 10% for FME). All cell
lines were routinely shown to be free of mycoplasma con-
tamination by fluorescence staining for cytoplasmic DNA
(Chen, 1977). Bulk cultures of late log-phase AA8 cells
(1.0-1.1 x 106cellsml-') were prepared in spinner flasks in
CM containing 10% FBS by adjusting the cell density to
5 x I05 ml-' 18 h before the experiment. Cells were harvested
by centrifugation and resuspended in fresh CM to 5 x 106
cellsml'. EMT6/Ak cells were prepared from multicellular
spheroids grown in spinner flasks to a diameter of approx-
imately 1 mm; these were dissociated by incubating for
30min with Pronase (0.5 mg ml-') and DNAse I (1.0mg
ml-') at 3rC. Cells were centrifuged and resuspended in CM
to provide a single-cell suspension at 2.5 x 106 cells ml-'.
FME cells were prepared by growing monolayer cultures in
100-mm-diameter tissue culture dishes to plateau phase
(4-5 x I0cells ml-'), harvesting by trypsinisation (0.07%
trypsin at 37'C for 10 min), pooling in CM containing
DNAse I (0.2 mgml-') and incubating at room temperature
for 15 min before centrifugation and resuspension to
2.5 x lI6cells ml' in fresh CM.
Cytotoxicity
Cytotoxicity was measured under controlled oxygenation in
continuously gassed and stirred suspension cultures, using a
modification of the method of Whillans and Rauth (1980).
The apparatus comprised up to six gassing manifolds in a
single 37C waterbath over two nine-position magnetic stir-
rers, each manifold supplying up to nine glass Universal
bottles (internal diameter 25 mm) containing cell suspensions
which were stirred with glass-coated magnetic stir bars. Com-
parison of killing under aerobic (concentration of oxygen in
gas phase (C.) 20%) and anoxic (C,<10 p.p.m. oxygen)
conditions was made using 10ml cultures at 106cellsml-'
(AA8) or 5 x lIO cells ml-' (EMT6/Ak and FME). These
were prepared by equilibrating drug solutions (8 ml) in CM
at 1.25 times the final required concentration at 37C, using
humidified gas mixtures containing 5% carbon dioxide
(flowing through each vial at l00mlmin-'), for 60min prior
to addition of cells (2 ml at five times the final cell density,
equilibrated under the same gassing conditions). Samples
were removed at intervals and colony formation assessed
after incubation at 37C for 8, 7 or 12 days (AA8, EMT6/Ak
and FME respectively). Cytotoxicity to AA8 cells at a more
extensive range of oxygen concentrations (typically with gas
phases of 0, 0.2, 1, 5, 20 and 95% oxygen plus 5% carbon
dioxide) was determined in the same manner using either I05
or 106cellsml'l, but the final culture volume was 6ml and
the lids were modified to allow insertion of an oxygen elec-
trode.
Measurement ofoxygen concentrations
Oxygen was measured using a Clark-type oxygen electrode
with a high-stability voltage supply and amplifier (Koch,
1991). In each experiment the electrode was calibrated in
20% oxygen, and the zero current measured from the anoxic
drug exposure vial, which was determined in separate
experiments to contain an oxygen concentration below the
limit of detection of the electrode (c. 20p.p.m. oxygen). The
oxygen concentrations reported have been corrected for the
current at zero oxygen (typically 10-20 pA). In experiments
involving C. intermediate between 0 and 20%, the oxygen
tension in solution (C,) was monitored continuously in the
1% oxygen vial and was measured in all other vials at the
end of the drug exposure. Values of C, are expressed as a
percentage of that for CM saturated with 100% oxygen
(1.01 mM).
Relationship between solution andgas-phase oxygen
concentrations
For continuously gassed, stirred cell suspensions such as the
above, the relationship between the gas-phase oxygen concen-
tration (C) and the steady-state concentration in solution at
infinite time (C,) is given by
C, =CS-Rkl (1)
where R is the rate of cellular oxygen consumption and k1 is
the geometry-depndent rate constant for the transport of
oxygen across the solution-gas phase interface (Degn &598 B.G. SIIM et al.
Wohlrab, 1971; Whillans & Rauth, 1980). k, was determined
by measuring the rate of deoxygenation in the absence of
cellular respiration by gassing CM (6 ml) with 95% nitro-
gen-5% carbon dioxide (<10 p.p.m. oxygen) under the above
standard conditions. The value of R for non-drug-treated
AA8 cells was determined from the rate of loss of oxygen in
aerobic AA8 cell suspensions (5 x IO6cellsml-') in sealed
respiration vials at 37C.
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Macromolecular adductformation by [3H]8Me-5NQ
Covalent binding of 8Me-5NQ metabolites to cellular mac-
romolecules was determined under the same conditions as the
AA8 cytotoxicity experiments except that [3H]8Me-5NQ was
added in a small volume (typically 20-30jd) to 6 ml of
pre-equilibrated cell suspension (106ml-'). At various times
triplicate samples of I0W cells were prepared from each vial by
diluting 10-fold into ice-cold phosphate-buffered saline, and
macromolecules were precipitated by adding cold 95% (v,v)
ethanol (nine volumes). The samples were mixed by vortexing
and stored at -20°C overnight. Precipitates were collected
by filtration onto glass fibre filters (Whatman GF/C) and
washed five times with 10 ml of cold 95% (v/v) ethanol and
radioactivity determined by scintillation counting.
Definition ofCio and K values
In experiments using a single drug concentration, the para-
meter used to quantify oxygen dependence was the Cm value,
defined as the C, required for 50% inhibition of the effect
(yield of adducts or log cell kill) observed under anoxia. In
experiments in which the drug concentration was adjusted to
determine cytotoxic potency (as 1/CT,O, where CT,0 is the
concentration x time required to reduce survival to 10% of
non-drug-treated controls), the oxygen dependence was
quantified as the K-value, where K is the C, when the potency
is the arithmetic mean of that under anoxia and at infinite
oxygen.
Results
Comparison ofhkpoxia-selective cytotoxicity in three cell lines
The rate of killing of human melanoma FME cells by 8Me-
5NQ was markedly enhanced under anoxic conditions rela-
tive to that under aerobic conditions (C. = 20%) (Figure 2).
The hypoxia-selective cytotoxicity of 8Me-5NQ, the ratio of
CTI0 values in aerobic and anoxic cultures, in the FME cell
line was 66 ± 13 (Table I). Similar experiments were per-
formed for 5NQ and 8NHMe-5NQ using FME cells (Table
I). 5NQ, with a CTIO ratio of 13 ± 2, had lower hypoxic
selectivity than 8Me-5NQ, while the cytotoxicity of 8NHMe-
5NQ towards FME cells was only marginally enhanced
under hypoxia (selectivity ratio 1.4 ± 0.1).
To test whether the differences in hypoxic selectivity of
8Me-5NQ, 5NQ, and 8NHMe-5NQ were cell line dependent.
similar experiments were performed using aerobic and anoxic
stirred suspension cultures of AA8 and EMT6/Ak cells
(Table I). In each of the cell lines 8NHMe-5NQ showed only
marginal selectivity, and 8Me-5NQ was more selective than
the parent 5NQ (Table I). Since the differences between these
drugs were consistently observed in all three lines, further
investigation of oxygen dependence was carried out using
AA8 as a representative cell line.
Bioreductive activation of8Me-SNQ
Labelling of the ethanol-insoluble (macromolecular) fraction
of AA8 cells by [3H]8Me-5NQ (40tiM) increased linearly with
time under anoxic conditions (Figure 3), resulting in binding
of 6.0% of the total radioactivity in anoxic cultures by 5 h.
This labelling was almost completely inhibited under aerobic
conditions, suggesting that 8Me-5NQ undergoes oxygen-in-
hibitable reductive activation to form a reactive species.
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Figure 2 Rate of killing of FME cells by 8Me-5NQ under
aerobic (a: 20% oxygen) and anoxic (b) conditions.
Intermediate orxgen tensions: characterisation ofexperimental
system
Drug cytotoxicity and metabolism were investigated over a
wider range of oxygen concentrations by varying the oxygen
content of the gas phase in the above stirred cell suspension
system. The relationship between C. and C, was first inves-
tigated using non-drug-treated AA8 cell cultures (6ml) at
densities of IO' and 106 cells ml-' (Figure 4). The measured
values of C, approached C. at high oxygen concentrations,
but at lower values of C. the effects of cellular oxygen
consumption in reducing C, were evident. At a density of
106cellsml`', this divergence became significant below a C.
of about 5%, but at 10 cellsml-' the effect of oxygen con-
sumption was observed only below 1% oxygen.
The relationship between C. and C, at high oxygen concen-
trations was accounted for well by equation (1) using experi-
mentally determined values of k,[0.14 ± 0.01 (s.e.m.)min-']
and R [3.6 ± 0.1 x I0-'7 (s.e.m.) molcell-' s'l], as shown by
the dashed lines in Figure 4. However, at low oxygen concen-
trations the measured values of C, were higher than predicted
by this equation, suggesting that R decreases under these
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Table I Aerobic and hypoxic cytotoxic potencies and hypoxic selectivity ratios for
5-nitroquinolines in stirred suspension cultures
Aerobic potency Hvpoxic potency Hjvpoxic selectivity
Drug Cell line CT,O (L hja CT,O (wh)a ratio CT,O (airNI,)"
8Me-5NQ FME 1,855 80 28 3 66 13
AA8 2,470 600 30 4 69 10
EMT6Ak 1.215±85 43 1 30±4
5NQ FME 350 20 24 1 13 2
AA8 775±40 52±4 13 1
EMT6 Ak 510 15 28 2 18 0.1
8NHMe-5NQ FME 2.245 ± 280 1,570 ± 230 1.4 ± 0.1
AA8 2,100 600f 2,180 170 1.2 ± olc
EMT6Ak 2,645 360 2,100 265 1.2 0.1
aValues are means ± s.e.m. for at least three determinations. bValues are means for
intra-experiment comparisons in at least two independent experiments. The ratio in each
experiment was determined from the pair of killing curves under air and nitrogen which gave
the most similar rates of killing. 'Data from Denny et al. (1992).
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Figure 3 Formation of ethanol-insoluble (macromolecular)
adducts from ['H]8Me-5NQ (401M) in AA8 cell cultures
(106cellsmV') under aerobic (0) and anoxic (0) conditions.
Error bars are ranges for two independent experiments.
Oxygen-dependence ofcvtotoxicity and metabolic activation
Killing of AA8 cells by 8Me-5NQ was examined over a range
of oxygen concentrations, using a drug exposure sufficient to
give measurable killing under anoxic conditions [surviving
fraction (SF) = 1.2 x 10-' and 8.4 x 10' in the two experi-
ments; Figure 5]. Cell killing (determined as -logl0 SF) was
inhibited by very low concentrations of oxygen, with a C,0
value of c. 0.01% oxygen. A similar oxygen dependence
experiment with 5NQ (50pM, 2 h) provided a SF of
2.1 x 10-' under anox.ia and also indicated a low C,o value of
c. 0.02% under these conditions (Figure 5, inset). Similar
experiments with MISO (10 mm, 2 h, IO6AA8 cells ml-')
indicated an oxygen sensitivity very similar to that reported
by Taylor and Rauth (1982), and gave a very low C,5, value
of c. 0.005% oxygen (data not shown).
The oxygen dependence of covalent binding of 8Me-5NQ
metabolites to macromolecules in AA8 cells was investigated
under the same conditions (Figure 5). Formation of adducts
at 2h (anoxic values 3.7, 1.0 and 1.9nmol 1O6cells-' in the
three experiments) showed an oxygen dependence very
similar to that for cell killing, with a Cm. value of c. 0.02%
oxygen. There was some suggestion of residual covalent bind-
ing at high C, (>1%), although these values were only
2-fold greater than the 'non-specific' binding assessed from
the ethanol-precipitable radioactivity in samples removed
1 min after addition of [3H]8Me-5NQ.
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Fgre 4 Relationship between oxygen concentrations in the gas
phase and in solution in stirred AA8 cell cultures at 0 (V), 105
(0) and 106 (A) cells ml-'. Error bars are s.e.m. for three
independent experiments.
In the above experiments, performed using a single drug
concentration. killing under aerobic conditions was too low
to measure. The rate of cell killing by 8Me-5NQ was deter-
mined in additional experiments using a range of drug con-
centrations (varying from 55liM under anoxia to 1,950gM in
95% oxygen) to enable quantitation of potency (as l CTIO)
over the full range of oxygen concentrations (Figure 6).
Cytotoxic potency decreased progressively to a minimum
value at 20% oxygen, with no further change when the
oxygen concentration was increased to 95%. The K-value for
8Me-5NQ was c. 0.02% oxygen.
Analogous oxygen dependence experiments were perform-
ed with 5NQ by varying the drug concentration from 50iJM
under anoxia to 1,000 JIM in cultures equilibrated with 95%
oxygen, to achieve a measurable rate of killing over the full
range of C, values. Like 8Me-5NQ, no further inhibition of
cytotoxicity was observed above 20% oxygen. The K-value
for 5NQ (c. 0.1% oxygen) appeared to be greater than for
8Me-5NQ (c. 0.02% oxygen). However, the increase in C,
with time after addition ofdrug to vials gassed at 1% oxygen
was much more marked with 5NQ than with 8Me-5NQ
under the conditions of these experiments (Figure 7) and
would lead to an overestimation of the K-value. The increase
in C, after addition of 5NQ was much less pronounced at a
lower cell density of 10 cells ml' (Figure 7). At the lower
density of 10 cells ml' extensive inhibition of killing by
5NQ (501AM, 2 h) was observed at the lowest oxygen concen-600 B.G. SIIM et al.
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Figure 7 Changes in oxygen concentration in solution (ordinate)
during incubation of AA8 cells with bioreductive drugs (CL,= 1%
oxygen). 0. 8Me-5NQ. 551M. 106 cells ml-': V. 5NQ. 50AM.
I06cells ml1 '. V. 5NQ. 50AM. IO cells ml '.
Fue 5 Oxygen dependence of cell killing (filled symbols) and
adduct formation (open symbols) after exposure of AA8 cells to
drugs (551M 8Me-5NQ. 50 JLM 5NQ) for 2 h. C, was determined
at the end of the drug exposure period. Different symbols refer to
separate experiments.
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The initial objective of this study was to assess whether the
highly hypoxia-selective cytotoxicity of 8Me-5NQ in Chinese
hamster AA8 cell cultures of 60-fold (Denny et al.. 1991.
1992) is observed in other cell lines. The results demonstrate
that this selectivity is not restricted to the AA8 line, with
selectivity ratios of 66 and 30 observed in the human
melanoma FME and murine carcinoma EMT6 Ak lines
respectively (Table I). Investigation of two further 4-
alkylamino-5-nitroquinolines. 5NQ and 8NHMe-5NQ, with
lower hypoxic selectivity in the AA8 line (Denny et al.. 1992)
indicated the same pattern of selectivity (8Me-5NQ > 5NQ
> 8NHMe-5NQ) in each of the three cell lines investigated.
The magnitude of the hypoxic selectivity was similar in each
line, although the air nitrogen differential of 8Me-5NQ
showed a minor variation (2-fold) between lines. Thus. based
on this limited comparison. the determinants of the hypoxia-
selective cytotoxicity of these 4-alkylamino-5-nitroquinolines
appear to be largely independent of species and cell line. The
AA8 cell line was therefore selected as representative for
further investigation of the oxygen dependence of cytotox-
icity and metabolic activation of these 5-nitroquinolines.
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Fue 6 Oxygen dependence of cytotoxic potency of 8Me-5NQ
(0) and 5NQ (0). Error bars (s.d.) are shown for replicate
determinations at C0 = 0 and 20% oxygen.
tration tested (C0 = 0.07%. C, = 0.016%. -log SF = 210% of
anoxic value), indicating (by extrapolation) a Cf0 value of c.
0.004% oxygen (data not shown).
Discssion
Lack ofcell line dependence ofhipoxia-selective ctotoxicit}
Some bioreductive drugs show marked variations in potency
and hypoxia-selective cytotoxicity between cell lines owing to
differences in repair or activity of bioactivating enzymes. For
example, the potency and hypoxic selectivity of quinoidal
HSCs such as mitomycin C and E09 is dependent on the cell
line, in part because of variations in expression of the two-
electron reductase NAD(P)H:quinone oxidoreductase (DT
diaphorase), which can activate such compounds in the
presence of oxygen (Hoban et al., 1990; Dulhanty & Whit-
more, 1991; Marshall et al., 1991a.b; Robertson et al..
1992).
Investigation ofintermediate oxYgen tensions
The major technical difficulty in working with cell cultures at
intermediate oxygen concentrations is that cellular respiration
can appreciably lower C. The steady-state value of C, in this
stirred system is a function of both the rate of transport of
oxygen into the solution. kl, and the rate of its consumption
by cells, R, as described by equation (I) (Degn & Wohlrab,
1971; Whillans & Rauth. 1980). The relationships between C0
and C, reported in Figure 4 agree closely with published data
(Taylor & Rauth. 1982; Marshall et al., 1986). and are
described well by equation (1) at high values of C.. The
discrepancy at low oxygen presumably reflects a decrease in
R as reported by others (Froese. 1962; Taylor & Rauth,
1982; Marshall et al.. 1986).
Inhibition ofrespiration by bioreductive drugs
It is essential to monitor actual values of C, in experiments of
this type since R is not well defined at low oxygen concentra-
tions, and can change with time in drug-treated cultures
(Taylor & Rauth, 1982; O'Brien et al., 1990). Time-
dependent increases in C, were observed with both of the
4-alkylamino-5-nitroquinolines investigated here (Figure 7),
presumably as a result of progressive inhibition of respira-
tion, as has been reported for MISO (Taylor & Rauth, 1982).
When such changes are marked, as with 5NQ in AA8 cul-
tures at 106cells ml', it is difficult to define the oxygen
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dependence of killing with precision. The C, values reported
here are for the end of the 2 h drug exposure period, and
thus overestimate oxygen concentrations during treatment.
The biasing effect of changing C, is illustrated by the reduc-
tion in the Cm value for 5NQ cytotoxicity from 0.02 to c.
0.004% oxygen when the cell density is lowered from 106 to
I0 cells ml-'.
The observed inhibition of oxygen consumption by these
bioreductive drugs has significnce beyond the above metho-
dological problem, since analogous changes in tumours could
increase the diffusion distance of oxygen and hence cause
significant reoxygenation. Drug-induced inhibition of respira-
tion has been shown to radiosensitise multicellular spheroids
through this mechanism (Biaglow & Durand, 1976, 1978;
Durand, 1976). Although this process is potentially advanta-
geous with radiosensitisers (since oxygen itself is a potent
radiosensitiser), bioreductive activation of HSC would be
compromised. The problem would be particularly severe for
compounds with cytotoxicity restricted to regions at extre-
mely low oxygen.
Covalent binding by metabolites of8Me-5NQ
Covalent binding to cellular macromolecules as a result of
reductive metabolism has been reported for many nitro-
(hetero)aromatics (e.g. Chapman et al., 1983; Wilson et al.,
1986; Liu et al., 1992). The inhibition of 8Me-5NQ binding
by oxygen strongly suggests that adduct formation depends
on reductive activation. Further, the similarity of the oxygen
dependence for cytotoxicity and binding to macromolecules
(C_v = 0.01 and 0.02% respectively) is evidence that this
metabolic activation is responsible for the toxicity of 8Me-
5NQ. This is consistent with studies with repair-deficient cell
lines suggesting that cytotoxicity of this compound is due to
formation of covalent DNA adducts (Denny et al., 1991,
1992). The observation of some residual binding at high
oxygen concentrations (Figure 5) has not been characterised
adequately, but may indicate that a threshold level of
adducts is required before cytotoxicity is observed and/or
that an oxygen insensitive pathway contributes to activa-
tion.
Oxygen dependence of8Me-5NQ and5NQ cytotoxicity
Both 5NQ and 8Me-5NQ have very low C_v values for
cytotoxicity, being in the order of 0.01% oxygen under stan-
dard conditions (2h exposure at I06cellsml-', using a drug
concentration giving c. 3-4 logs of kIilling under anoxia).
These 4-alkylamino-5-nitroquinolines show a similar oxygen
dependence to that reported for bioreductive drugs from a
number of different drug classes: the nitro(hetero)arenes
MISO (Taylor & Rauth, 1982; Mulcahy, 1984) and RSU
1069 (Koch, 1993); the quinones mitomycin C (Marshall &
Rauth, 1986; Rauth & Marshall 1990), porfiromycin (Mar-
shall & Rauth, 1988) and diaziquone (O'Brien et al., 1990;
Rauth & Marshall, 1990); and the cobalt complex SN 24771
(Wilson et al., 1994). In each ofthese cases 50% inhibition of
the anoxic cell kill required c. 0.01% oxygen. As noted
above, the true C_v values for the 5-nitroquinolines in the
present study may be even lower than the -estimates at
l06cellsml-', as is demonstrated by the very low C_0 for
5NQ (c. 0.004% oxygen) at a density of I0 cellsml-'. All of
these compounds differ from the benzotriazine N-oxide
tirapazamine (SR 4233), which requires substantially higher
oxygen concentrations for inhibition of cytotoxicity (Koch,
1993).
Since the initial clinical use of bioreductive drugs is
expected to be in combination with radiotherapy, it is appro-
priate to compare the oxygen dependence of these drugs with
that for radiation. The relationship between radiosensitivity
and oxygen concentration is described by a semiempirical
hyperbolic function, the Alper and Howard-Flanders equa-
tion (Alper & Howard-Flanders, 1956), which contains two
parameters: the OER (the differential in potency between
infinite and zero oxygen) and the K-value. The latter is equal
to the oxygen concentration giving a radiosensitivity
(cytotoxic potency) that is the arithmetic mean of the values
at zero and infinite oxygen. For an HSC a K-value can be
defined in the same manner. The data of Figure 6 provide
K-values of c. 0.02 and 0.1% oxygen for 8Me-5NQ and 5NQ
respectively. The apparent difference between the two drugs
may be an artifact due to the greater effect of 5NQ on
cellular respiration.
8Me-5NQ resembles other nitro compounds in that its
cytotoxicity is inhibited at very low oxygen concentrations. It
is of interest to ask whether the observed K-value is consis-
tent with the proposed mechanism of inhibition of activation
by oxygen (Figure 8). At the K-value the concentration of
ArNO2 required for isoeffect [ArNO2,J is 2-fold higher than
under anoxia ([ArNO,J,), but since the rate of killing is the
same under both conditions the steady state concentration of
ArNO2- will be equal. Thus:
[ArNO2J6 = i[ArNOjK (2)
[ArNO2]o- = [ArNO2iK (3)
where [ArNO2i-]6 is the concentration of ArNO2- under
anoxia and [ArNO2'*h is the concentration of ArNO2- at
the K-value. Assuming homogeneous kinetics (uniform distri-
bution of ArNO2- and oxygen) and steady-state conditions
for ArNO2-, from Figure 8:
[ArNO2,-lc = -kkO2J + (k2[021 + 8k,k3[ArNOJS
4k3
[ArNO2- = (4klk3[ArNO2J,J
4k3
Solving equations (2-5) for [OJ = K gives:
K =(k,k3[ArNO,Jd
k2
(4)
(5)
(6)
The value of k, was determined from the rate loss of
8Me-5NQ in AA8 cultures under these conditions (106cells
ml-', 40 lM 8Me-5NQ, anoxia; Siim et al., 1994). Assuming
that there are two molecules of ArNO2- formed for each
molecule ofArNO2 lost (Figure 8), this gave k, = 1.4 x 10-4
s-'. Values of 8 x 10 M-1 s-1 and 2.5 x 106 M-' s- for k2
and k3 respectively for 8Me-5NQ have been determined by
pulse radiolysis (P. Wardman, personal communication).
Using these values, plus [ArNO2]K= 120ILM (from Figure 6),
the predicted K-value for 8Me-5NQ is 256 nM (0.025%
oxygen). The agreement between the measured (c. 0.02%)
and prdicted K-values for 8Me-5NQ supports the assump-
tion that ArNO2*- and oxygen are isotropically distributed
throughout the experimental system and suggests that the
very low K-values for cytotoxicity of nitro compounds are
accounted for by the rapid kinetics of back-oxidation of the
radical by oxygen relative to further reduction via dispropor-
tionation.
In addition to K-values, plots of potency as a function of
oxygen concentration provide information about the mechan-
ism(s) of cytotoxicity. The potencies of 8Me-5NQ and 5NQ
are not lowered further when the oxygen concentration is
ArNO2 - - ArNO2- ArNO
02.- 02
Fugwe 8 Reduction scheme for one-electron reduction ofArNO2
to ArNO20- and loss of ArNO20- through disproportionation
or reaction with oxygen. k, = rate constant for one-electron
reduction of ArNO2; k2 = rate constant for reaction of ArNO2-
with oxygen; k3 = rate constant for disproportionation of ArNO2-e602 B.G. SIIM et al.
raised from 20 to 95% (Figure 6)., so the selectivity ratios at
supraphysiological oxygen are the same as the ratios for 0
and 20% oxygen (Table I). The failure to suppress cytotox-
icity further at high oxygen concentrations is inconsistent
with net reduction being the only mechanism of cytotoxicity.
The high rates of reduction and one electron redox cycling of
these 5-nitroquinolines (Siim et al., 1994) suggests that reac-
tive oxygen species may contribute to cytotoxicity at high
oxygen concentrations. This is consistent with the observed
plateau in toxicity at high oxygen since when oxygen >> K
formation of the nitro radical will be rate limiting for
superoxide formation, which will therefore not increase as
oxygen is raised further. The higher aerobic potency (and
lower hypoxic selectivity) of 5NQ than 8Me-5NQ (Table I)
may reflect a greater contribution of oxygen species to
cytotoxicity for 5NQ, which would be consistent with the
higher rate of oxygen consumption induced in cyanide-
inhibited AA8 cells by 5NQ than 8Me5NQ (Siim et al..
1994).
Modelling ofoxvgen dependence ofcell killingfrom
drug + radiation
Although convenient, parameters such as the C^0, K-value, or
hypoxia-selective cytotoxicity ratio do not describe fully the
oxygen dependence of bioreductive drugs. The interaction of
bioreductive drugs with radiation in killing cells in tumours
can only be assessed adequately by modelling this interaction
using the estimated cell kill due to both agents alone over the
full range of oxygen tensions. The results of this calculation
are illustrated for the combination of 8Me-5NQ with a single
dose of ionising radiation (2 Gy) in Figure 9, using the
oxygen dependence of cell kill by 8Me-5NQ reported in
Figure 5 and published oxygen dependence data for the
radiosensitivity of CHO cells (Whillans & Hunt, 1982), and
assuming an OER of 2.5 at a dose of 2 Gy. SF values due to
radiation were calculated using the linear-quadratic model
assuming x = 0.3 Gy' and P = 0.03 Gy-2 at 20% oxygen,
these parameters being typical for human cells (Fertil &
Malaise, 1985). If it is assumed that anoxic cell killing due to
the drug is the same as that achieved by radiation in the oxic
subpopulation (SF = 0.5), then cells at intermediate oxygen
are spared by this combination. However, if sufficient drug
can be delivered to kill four logs of anoxic cells, then the
resistance at intermediate oxygen disappears (Figure 9). Such
extensive killing is unlikely if hypoxia is predominantly the
result of fluctuating tumour blood flow; cells which are
radioresistant because a vessel has recently closed may reox-
ygenate because of reopening of the vessel, thus terminating
hypoxic drug exposure. However, it is clear that the mag-
nitude of the problem at intermediate oxygen concentrations
depends critically on the absolute cell kill which can be
achieved with a bioreductive drug, and cannot be assessed
adequately by comparing the relative sensitivities of drug and
radiation to oxygen. The importance of using absolute rather
than relative parameters to describe modification of radiation
response has been emphasised recently (Koch & Skov,
1992).
Implicationsfor therapeutic use
This study has identified two problems which may limit the
activity of 4-alkylamino-5-nitroquinoline drugs in bioreduc-
tive radiotherapy. Inhibition of respiration by these com-
pounds could increase diffusion of oxcygen and eliminate the
microenvironments best able to activate the compound. Fur-
ther, cells at 'intermediate' oxcygen tensions will be relatively
resistant to both radiation and the drug. The extent of this
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Figure 9 Combination of 8Me-5NQ with radiation at a range of
oxygen concentrations. 0; low-dose 8Me-5NQ (anoxic SF = 0.5);
*. high-dose 8Me-5NQ (anoxic SF = 10-4); 0. radiation only
(2 Gy); solid line without symbols. low-dose 8Me-5NQ plus
radiation; dashed line. high-dose 8Me-5NQ plus radiation.
problem will depend on the drug concentration which can be
achieved in tumours. The maximum tolerated dose of 8Me-
5NQ in C3H/HeN mice is only 100tLmol kg-' (Denny et al.,
1992), suggesting that concentrations in tumours of > 100
#lM are not likely to be achieved. Since a concentra-
tion x time of c. 50gLM h is required for appreciable killing of
even fully anoxic cells by 8Me-5NQ in vitro (Figure 6),
extensive killing of these cells in mouse tumours is unlikely.
These problems, along with restricted tissue penetration
imposed by non-covalent DNA binding (Durand, 1986; Wil-
son & Denny, 1992), may account for the disappointing lack
of activity of 5NQ and 8Me-5NQ as tumour radiosensitisers
in vivo (Denny et al., 1992; Wilson et al., 1992).
The investigation of these model compounds has pointed
to the difficulty of de novo design of bioreductive drugs.
Development of compounds with high differential toxicity in
standard in vitro screens is a first step, but there are many
potential problems which may preclude in vivo activity. There
is thus an obvious need to evaluate new candidate com-
pounds in vivo at an early stage in any bioreductive drug
development programme.
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concentration of oxygen in solution; CM, culture medium [cx-MEM
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and 100ygml-' streptomycinJ; CT,0, concentration x time to reduce
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s.d., standard deviation; s.e.m., standard error of the mean; SF,
suruvivng fraction.
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